Learn more

CEL SCI CORP

Overview
  • Total Patents
    72
  • GoodIP Patent Rank
    207,044
About

CEL SCI CORP has a total of 72 patent applications. Its first patent ever was published in 1989. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are MEHTA NOZER M, JACKSON SIMON MARK and INST OF BASIC MEDICINE CHINESE.

Patent filings per year

Chart showing CEL SCI CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zimmerman Daniel H 34
#2 Talor Eyal 21
#3 Sarin Prem S 11
#4 Rosenthal Kenneth S 9
#5 Talor Eyal I 7
#6 Zimmerman Daniel S 6
#7 Kersten Geert 5
#8 Charoenvit Yupin 3
#9 Eyal Talor 3
#10 Mikecz Katalin 3

Latest patents

Publication Filing date Title
WO2020231942A1 Peptides and conjugates for treatment of arthritis
EP2989121A1 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
WO2012162565A2 Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
WO2012162564A1 Method for inducing an immune response and formulations thereof
WO2012082803A2 Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
WO2009114869A2 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
US2008131396A1 Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor
US2006257420A1 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
US2006088544A1 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
AU2005269400A1 A method for managing cholesterol with a serum-free and mitogen free cytokine mixture
AU2005260053A1 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture
CA2568295A1 A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor
US2006257357A1 Method for modulating HLA class II tumor cell surface expression with a cytokine mixture
US6896879B2 Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
AU2003210594A1 Peptide constructs for treating disease
WO03061589A2 Methods for treating diseases or conditions with peptide constructs
US6951647B2 T cell binding ligand peptides and method of inducing a cellular immune response
WO0189286A2 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders
AU4134901A Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
US6995237B1 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions